Used primarily as an intermediate in the synthesis of anticoagulant pharmaceuticals, particularly in the production of potent platelet aggregation inhibitors. Its chiral structure makes it valuable in developing enantiomerically pure drugs targeting cardiovascular diseases. The compound plays a key role in optimizing metabolic stability and receptor selectivity in final drug formulations. It is also employed in research settings for structure-activity relationship studies aimed at improving thrombin inhibition and reducing bleeding risks in next-generation antithrombotics.